In experimental models of NAFLD, AGEs have been described to exacerbate liver injury, fibrosis and inflammation [10,11,16] mainly through stimulation of the receptor for advanced glycation end products (RAGE) which in turn activate oxidative and inflammatory pathways [10,17]. Here, AGER is linked to metabolic dysfunction-associated steatotic liver disease.